Medical marketing strategy changes by vertical because the unit being bought changes. A med spa is selling a relationship measured in retained member-months, a dental implant practice is selling a single treatment plan worth twenty thousand dollars, and a fertility clinic is selling a decision the patient will research for four months before making. Those are three different businesses that happen to share a category label, and running them on the same campaign structure, attribution window, and follow-up cadence produces three underperforming accounts.
This post lays out what actually differs across the five verticals ClinicAds works in, what stays constant, and how to tell whether the agency you are paying is running a genuine per-vertical strategy or one playbook with the logo swapped.
- The three systems stay constant across every vertical we serve: search visibility, paid media, and speed-to-lead follow-up. What changes is the unit those systems are optimized against, and that single choice cascades into every other decision in the account.
- Five verticals, five units. Plastic surgery counts booked procedures, med spas count retained members, dental counts accepted treatment plans, telehealth counts CAC payback, and specialty clinics count qualified consults inside a decision window that can run six months.
- Attribution window is the most commonly mismatched setting in healthcare advertising. A 7-day click window is roughly correct for a med spa filler promotion and completely wrong for a fertility clinic, where the gap between first click and booked consult routinely exceeds 90 days.
- Ad policy is not uniform across medical categories. Dental before-and-after imagery is generally workable where the same asset for an aesthetic injectable is not, and regenerative medicine sits under claims-substantiation exposure that neither of them face.
- The cheapest lead usually belongs to the vertical where a lead is worth the least. Optimizing every account toward a low cost per lead is how an agency produces five identical reports and five different disappointments.
What stays the same: three systems
Every practice we work with runs the same three systems. Search visibility covers SEO, local pack presence, and the entity and schema work that makes ChatGPT, Perplexity, and Google AI Overviews name the practice when a patient asks who to see. Paid media covers Meta and Google, operated together rather than as two disconnected line items. Speed-to-lead follow-up answers every inquiry by SMS within minutes, qualifies before the calendar fills, and runs the confirmation and reminder cadence that protects the appointment.
That much is constant, and it is constant for a defensible reason: the failure modes are universal. Every practice we audit is losing patients to slow follow-up, invisible to AI assistants, and running paid media measured against a number that does not pay rent. The systems address those three failures regardless of specialty.
What is not constant is what those systems are pointed at. That is the whole argument of this post, and it is the part most agencies skip.
The unit of measurement is the strategy
Pick the unit first and most other decisions follow from it. Pick it wrong and every downstream setting inherits the error, which is why an account can look competently managed and still produce nothing the practice owner values.
Here is what each vertical is actually measured on, and how long it takes before the number means anything. Ranges are agency averages across our accounts, not guarantees, and they move with market density and offer.
| Vertical | Unit that counts | Typical cost per unit | Result readable at |
|---|---|---|---|
| Plastic surgery | Booked procedure | $5,000–$10,000/mo spend at 5–10x ROAS | 60–90 days |
| Med spa | Retained member | $28–$80 per booked consult | 30–60 days |
| Dental | Accepted treatment plan | $150–$400 per high-value consult | 60–90 days |
| Telehealth | Paying patient, then CAC payback | $90–$250 CAC | 60–90 days |
| Specialty clinic | Qualified consult | $200–$600 per qualified consult | 90–120 days |
Plastic surgery: the consult is the product
A plastic surgery practice has finite operating room time and a surgeon whose hours are the constraint on the entire business. That makes the strategic question narrow: which consults deserve those hours, and how do you fill the schedule with them rather than with price shoppers.
So campaigns optimize toward booked consults with procedure intent, not toward form fills. Creative leads with the surgeon, because board certification and surgical judgment are the actual purchase criteria at this price point and a patient choosing a surgeon is choosing a person. Before-and-after imagery runs into real platform restrictions on Meta, so the media plan leans on surgeon-led video and patient-story content that carries the same persuasive weight without triggering review.
The mistake we see most often here is an agency reporting a low cost per lead on a practice that is turning away consults because too few of them are surgical candidates. Cost per lead went down. Surgeon utilization went down with it.
Med spas: the second visit is the product
A med spa has almost the inverse problem. Treatment prices are low enough that a first appointment rarely pays for its own acquisition, and the business only works if that patient comes back. A neurotoxin client returns three or four times a year for as long as the relationship lasts, which means the entire economic case rests on retention rather than on the first booking.
That changes the target. Campaigns optimize toward the treatments that reliably produce a second visit rather than toward whatever converts cheapest, because a discounted one-off promotion can hit an excellent cost per booking and still lose money over twelve months. Offers get framed against a membership or a program rather than a single discounted session. The follow-up system carries rebooking and reactivation, not just confirmation.
Attribution is also fastest here. Med spa decisions are comparatively low-consideration, and most bookings land within a couple of weeks of first click, which is the one vertical where a short attribution window is roughly honest.
Dental: the treatment plan is the product
Dental practices are drowning in leads. Free consultation offers convert at extremely low cost, which is exactly the problem: they fill the schedule with people who were price-comparing and were never going to accept a twenty-eight thousand dollar full-arch plan. The dental metric that matters is case acceptance, the share of presented treatment plans that get signed, and no amount of cheap lead volume improves it.
So dental campaigns optimize against consult value rather than lead count, and the creative pre-frames the investment instead of hiding it behind a free offer. Financing gets addressed in the ad and on the landing page rather than being sprung on the patient in the treatment room, because financing readiness is the single largest predictor of whether a plan gets accepted.
The follow-up system does the heaviest lifting of any vertical here. SMS qualification screens for budget and treatment readiness before the consult is booked, reminder sequences protect the appointment, and a reactivation track works the presented-but-unaccepted plans, which for most practices is the largest pool of recoverable revenue in the building and the one nobody is working.
Ad policy is also meaningfully looser than in aesthetics. Dental before-and-after imagery is generally workable where the same asset for an injectable would be rejected, so the creative strategy can lean on visual proof in a way the aesthetic verticals cannot.
Telehealth: the subscription tail is the product
DTC telehealth is not a clinic at all in the economic sense. It is a subscription business with a prescriber attached, and its numbers behave accordingly: acquisition cost, lifetime value, payback period, and churn. First-order return on ad spend is nearly meaningless, because a brand can run a deeply negative first order and still be extremely healthy if the subscription tail holds.
That means campaigns optimize toward paying patients and subscription starts rather than signups, and the report leads with CAC payback period rather than ROAS. Retention automation is a core part of the acquisition system rather than a separate lifecycle project, because a two-month improvement in average retention moves the business more than a ten percent improvement in CAC.
Compliance exposure is also sharpest here, and it is not theoretical. The FTC actions against Cerebral and BetterHelp both originated in tracking pixels transmitting patient data to advertising platforms. That is the single reason measurement infrastructure gets built before any campaign launches in this vertical rather than after.
Specialty clinics: the decision window is the product
Fertility, dermatology, regenerative, vein, and vision practices share a buying pattern rather than a procedure. The patient researches for weeks or months, the treatment is expensive, and the advertising category is the most tightly regulated of any vertical we serve.
The dominant technical problem here is attribution. Platform reporting defaults to a 7-day click window while the real gap between first click and booked consult regularly exceeds 90 days. The campaign that actually produced the patient therefore shows zero conversions, gets paused for underperformance, and the credit lands on whichever retargeting ad happened to be last in the path. We have inherited more than one specialty account where the best-performing campaign had already been switched off for exactly this reason.
Targeting is also constrained in ways other verticals are not. Platforms prohibit targeting on health status, and fertility is among the most strictly enforced categories, so reach gets built through interest, life-stage, and lookalike modeling alongside condition-first organic content. The patient needs to find the clinic rather than feel identified by it.
Regenerative medicine carries an additional layer. Many regenerative products are not FDA-approved for the uses clinics want to advertise, and the FTC has brought enforcement actions over unsubstantiated regenerative claims. Every asset goes through claims substantiation review before it reaches an ad account, and claims the clinic's evidence does not support do not run at all.
Four levers that move when the vertical moves
Underneath the vertical-specific detail, four settings change. If an agency cannot tell you how they set these for your specialty, they are running one playbook.
- Attribution window. Should match the real gap between click and booking, not the platform default. Wrong here and every other number in the report is wrong downstream.
- Creative and claims policy. Before-and-after imagery, efficacy claims, and personal-attribute targeting are each permitted, restricted, or prohibited depending on the category. This is checked before production, not after a rejection.
- Offer framing. Free consultation offers work in some verticals and actively damage others. In dental and plastic surgery they select for exactly the patients you do not want.
- Follow-up cadence. A med spa lead goes cold in days. A fertility lead is still deciding four months later. The same automation sequence cannot serve both, and sending the med spa cadence to a specialty lead reads as pressure.
| Vertical | Typical click-to-booking gap | Window we measure on |
|---|---|---|
| Med spa | 1–14 days | 30 days |
| Plastic surgery | 14–90 days | 90 days |
| Dental | 14–90 days | 90 days |
| Telehealth | 0–7 days to first order | 90 days for payback |
| Specialty clinic | 30–180 days | 180 days |
How to tell whether your agency has a per-vertical strategy
This is diagnosable in one conversation. Ask four questions and listen for whether the answers are specific to your specialty or generic to healthcare.
- What number are we optimizing toward, and why that one for my specialty? A vertical-aware answer names a unit, not a channel.
- What attribution window are we measuring on, and how did you arrive at it? If the answer is the platform default, nobody has thought about your decision timeline.
- Which of my claims can we not make in an ad? An agency that has done the policy work for your category will have a specific list. One that has not will say compliance is handled.
- Show me the report you send a client in a different vertical. If it is the same report with different numbers, you are getting the same strategy with different numbers.
Does medical marketing strategy really differ that much by specialty?
Yes, because the unit being sold differs. A med spa is measured on retained members, a dental implant practice on accepted treatment plans, and a fertility clinic on qualified consults inside a decision window that can exceed six months. Those three require different attribution windows, different offer framing, and different follow-up cadences. The three underlying systems stay the same; what they are optimized against does not.
Why does the attribution window matter so much?
Because it determines which campaigns appear to work. Advertising platforms default to a 7-day click window. If your patients typically take 90 days between first click and booked consult, the campaign that actually produced them reports zero conversions and gets paused for underperformance, while credit lands on whichever ad was last in the path. This is the most common cause of a well-run specialty account being dismantled by its own reporting.
Can dental practices use before-and-after photos in ads when med spas cannot?
Generally yes. Dental sits under health-related advertising rather than the tighter restrictions applied to prescription treatment and aesthetic procedures, so before-and-after imagery is usually workable where the equivalent injectable asset would be rejected. Personal-attribute rules still apply in both cases, meaning creative cannot imply knowledge of a specific person's condition. Every asset should get a policy review before launch regardless of category.
Why is a low cost per lead a bad target for high-ticket practices?
Because the offers that produce the cheapest leads select for the patients least likely to proceed. A free consultation ad converts cheaply and fills a dental or plastic surgery schedule with price comparison shoppers, which lowers cost per lead while raising cost per accepted case. Those two numbers move in opposite directions, and only one of them pays for surgeon or chair time.
Can regenerative and stem cell clinics be advertised at all?
Cautiously and with real limits. Many regenerative products are not FDA-approved for the uses clinics want to advertise, and the FTC has brought enforcement actions over unsubstantiated regenerative treatment claims. In practice a clinic can advertise its physicians, credentials, and consultation alongside factually substantiated information, but efficacy claims the clinic's evidence does not support should not run. Any clinic in this category should have its claims reviewed by healthcare counsel before running media.
Does HIPAA apply differently across these verticals?
The obligation is the same for every covered entity, but the exposure is sharpest where an inquiry itself reveals a diagnosis, which is the case in specialty and telehealth more than in aesthetics. The controls do not change: a signed Business Associate Agreement, server-side conversion tracking, hashed identifiers, and protected health information stripped from confirmation URLs before anything reaches an advertising platform.